Ning Li

发表

Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer

Jie Ma, K. Guo, S. Luo, 2014, Medical Oncology.

Phosphorylated insulin-like growth factor-1 receptor expression predicts poor prognosis of Chinese patients with gastric cancer

You-wei Zhang, X. Wan, S. Luo, 2014, Medical Oncology.

Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors

Q. Gao, L. Bie, S. Luo, 2022, Cancer Immunology, Immunotherapy.

Relationship between the expression of ERCC-1, survivin and both efficiency and prognosis of cisplatin contained first-line chemotherapy in advanced lung adenocarcinoma

Yongping Song, Xiaobing Chen, S. Luo, 2009 .

Evaluation of PAX8 expression promotes the proliferation of stomach Cancer cells

Xiao-yu Lu, P. Guo, L. Bie, 2019, BMC Molecular and Cell Biology.

Relationship between expression of CEA, E-cadherin and liver metastasis in colorectal cancer

Xiaobing Chen, L. Zhang, X. Wan, 2008 .

Clinical observation and therapeutic evaluation of Rh-endostatin combined with DP regimen in treating patients with advanced esophageal cancer.

T. Song, Xiang Li, S. Luo, 2014, Asian Pacific journal of cancer prevention : APJCP.

A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma

Y. Cheng, B. Tan, L. Bie, 2022, BMC medicine.

Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen

P. Guo, L. Bie, S. Luo, 2020, OncoTargets and therapy.

Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes

Kangdong Liu, Shuyi Wang, W. Shen, 2021, Briefings Bioinform..

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Kongming Wu, Mengke Niu, Ming Yi, 2021, Experimental Hematology & Oncology.

SOX13 dependent PAX8 expression promotes the proliferation of gastric carcinoma cells

Xiao-Bing Chen, L. Bie, Dan-guang Li, 2019, Artificial cells, nanomedicine, and biotechnology.

Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway.

Yongjun Guo, Zhenjiang Zhao, Beibei Chen, 2018, International journal of molecular medicine.

Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.

Youwei Zhang, X. Wan, S. Luo, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

E. Van Cutsem, J. Tabernero, Y. Janjigian, 2021, Nature.

Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer

Jian Cao, Miao-miao Sun, Zhi Li, 2019, World journal of gastroenterology.

Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer

S. Luo, Ning Li, W. Deng, 2021, Bioengineered.

Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Bin Zhang, L. Bie, X. Wan, 2021 .

Noninvasive Imaging of Tumor PD-L1 Expression Using [99mTc]Tc-Labeled KN035 with SPECT/CT.

J. Qu, Yingying Zhang, Ning Li, 2022, Molecular pharmaceutics.

Roles of Microvesicles in Tumor Progression and Clinical Applications

Kongming Wu, Ming Yi, Shiyu Li, 2021, International journal of nanomedicine.

Advances of Targeted Therapy for Hepatocellular Carcinoma

Mengke Niu, Ming Yi, Ning Li, 2021, Frontiers in Oncology.

Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study

Mengke Niu, S. Luo, Ning Li, 2021, Cancer management and research.

LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.

Bin Zhang, X. Hou, Jian Yang, 2020, Carcinogenesis.

Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for patients with advanced ESCC: A multicenter, single-arm, open-label phase Ⅱ clinical trial.

Yufeng Cheng, Y. Hong, S. Luo, 2021 .

Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors

Q. Gao, L. Bie, S. Luo, 2022, Cancer Immunology, Immunotherapy.

Clinical features and the efficacy of adjuvant chemotherapy in resectable small bowel adenocarcinoma: a single-center, long-term analysis

Han Yang, L. Bie, S. Luo, 2020, Annals of translational medicine.

Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival

S. Luo, Ning Li, W. Deng, 2015, Digestive Diseases and Sciences.

Prognostic impact of examined lymph-node count for patients with esophageal cancer: development and validation prediction model

S. Luo, Ning Li, W. Deng, 2023, Scientific Reports.

Long noncoding RNA FER1L4 suppresses proliferation, invasion, migration and lymphatic metastasis of gastric cancer cells through inhibiting the Hippo-YAP signaling pathway.

S. Luo, Ning Li, W. Deng, 2020, American journal of translational research.

Decreased expression of miR-542-3p exerts growth inhibitory functions in esophageal cancer.

Xiao-Bing Chen, Bei-bei Chen, L. Bie, 2015, Journal of Cancer Research and Therapeutics.

Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen

Ping Guo, L. Bie, Ning Li, 2020 .

Clinical observation and therapeutic evaluation of intravenous pump of recombinant human endostatin combined with TP regimen in treating patients with advanced ovarian cancer

S. Luo, Ning Li, W. Deng, 2015, Chronic diseases and translational medicine.

Phase II study of SHR1210 and trastuzumab in combination with CAPOX for neoadjuvant treatment of HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Bin Zhang, L. Bie, X. Wan, 2022, Journal of Clinical Oncology.

Molecular mechanism of indirubin-3'-monoxime and Matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line.

Xiao-Bing Chen, Bei-bei Chen, S. Luo, 2013, Chinese medical journal.